The aim of the study was to evaluate two putative cancer stem cell markers, CD133 and CXCR4, in the NCI 60 cell lines to identify a cancer stem cell rich population as in vitro models and suggestive for translational studies in patients. The gene discussed is CXCR4; the disease is cancer.